This message was sent to ##Email##
|
|
|
|
|
|
As 2019 comes to a close, ASCLS would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of ASCLS eNewsBytes a look at the most accessed articles from the year. Our regular publication will resume Tuesday, Jan. 7.
|
60 Minutes
From April 30: When antibiotics were first used in the 1940s they were a revolution in medicine. Before that, diseases like pneumonia and tuberculosis were often a death sentence, and even an infected scratch could be fatal. Since then, antibiotics have saved hundreds of millions of lives. But now many of these drugs are becoming ineffective.
READ MORE
Medical News Today
From Aug. 6: Extensive research into the role of the tumor suppressor p53 offers a greater understanding of the genetic mutations that are at play in various forms of cancer, as well as identifying four genes that may help predict a person's outlook.
The TP53 gene is responsible for encoding what scientists call tumor protein p53 — a tumor suppressor that can stop cells from dividing and proliferating too fast.
READ MORE
|
Promoted by
|
|
|
|
 |
Outbreak News Today
From Oct. 29: The Los Angeles County Department of Public Health reports investigating the 19th measles case of the year in a county resident.
Other people may have been exposed to measles since public locations were visited by the person with measles while infectious.
READ MORE
 |
|
The miniiSED™ is the newest addition to the iSED™ family of ESR analyzers from ALCOR Scientific. The miniiSED™ is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED™ is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
American Society for Microbiology via Infection Control Today
From July 30: Global warming may have played a pivotal role in the emergence of Candida auris, according to a new study published in mBio, an open-access journal of the American Society for Microbiology. C. auris, which is often multidrug resistant and is a serious public health threat, may be the first example of a new fungal disease emerging from climate change.
READ MORE
Medical News Today
From Sept. 20: A new device uses a smartphone and a paper microfluidic chip to detect extremely low levels of norovirus.
Norovirus is a very contagious virus responsible for around 19-21 million yearly cases of acute gastroenteritis in the United States.
READ MORE
NPR
From Aug. 20: With antibiotic-resistant bacteria on the rise, scientists are urgently trying to find drugs that will work against persistent infections. But coming up with new ones does not have to be the only strategy. A recent study published in Proceedings of the National Academy of Sciences found that they can repurpose bithionol — a drug formerly used to treat parasitic infections in horses — to kill antibiotic-resistant bacteria, including MRSA, a common hospital-acquired infection.
READ MORE
|
|
Rush University Medical Center via Infection Control Today
From March 12: Each year, approximately 5 million patients in the U.S. receive treatment that includes the insertion of a medical device such as a catheter, which puts them at increased risk of potentially life-threatening infection. Researchers have found a strategy that greatly reduced both overall infection and infection with antibiotic-resistant bacteria in a group of these patients.
READ MORE
Advertisement
|
|
CIDRAP
From June 18: A child who has never been vaccinated against pertussis, or whooping cough, is 13 times more likely to suffer from an infection of Bordetella pertussis than is a child who is up-to-date on his or her vaccines. But new evidence from a decadelong study at Kaiser Permanente shows that vaccinated children were five times more likely to suffer from whooping cough if it had been more than three years since their last vaccine dose.
READ MORE
Science News
From Aug. 20: Since its debut in 2012, CRISPR gene editing has held the promise of curing most of the over 6,000 known genetic diseases. Now it’s being put to the test.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests.
Learn more
|
|
|
|
Dark Daily
From July 16: Healthcare reforms that curb costs while improving outcomes have been an elusive goal at both the federal and private insurance levels. Now, Walmart may have found a plan that works, and it may have implications for clinical laboratories.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
